Skip to main content

Child and Adolescent Research Collaboration Group

Research Mission

The mission of the Child and Adolescent Psychiatry Section is to conduct research on psychiatric disorders affecting youth and their families; to provide excellent multidisciplinary training to the next generation of mental health providers and investigators; to deliver a broad range of innovative clinical services to young people and their families; to provide subspecialty consultation to clinicians throughout the state of Kansas; and to represent the mental health needs of children and adolescents at all levels of policy planning.

Recent Studies

  • Pediatric Bipolar Disorder Study and the Effects of Lithium (CoLT)
    • Study Details: A randomized, double-blind, placebo controlled study of the efficacy of lithium for the treatment of pediatric mania followed by an open label long-term safety period, double-blind, placebo-controlled discontinuation phase, and open label restabilization period.
    • End Date: 2013
  • Pediatric Bipolar Pharmacogenetics Study and Lithium Response (CoLT-PG)
    • Study Details: The purpose of this study is to identify genes associated with lithium response, both in terms of efficacy and tolerability, by performing an association study of genes known to be related to lithium mechanism of action.
    • End Date: 2013
  • Adolescent Schizophrenia and Bipolar Disorder and the use of Abilify (Otsuka-267)
    • Study Details: The aim of this study is to evaluate the safety and tolerability of treatment in adolescent patients with schizophrenia or child and adolescent patients with Bipolar I Disorder, manic or mixed episode with or without psychotic features
    • End Date: Estimate 5 years
  • Adolescent Schizophrenia and the use of Asenapine (Merck-P05896)
    • Study Details: An 8-week, placebo-controlled, double-blind, randomized, fixed-dose efficacy and safety trial of Asenapine in adolescent subjects with schizophrenia.
    • End Date: 2013
  • Adolescent Schizophrenia and the use of Asenapine (Merck-P05897)
    • Study Details: A 26-week, multi-Center, open-label, flexible dose, long-term safety trial of Asenapine in adolescent subjects with schizophrenia.
    • End Date: 2013
  • Pediatric Bipolar Disorder and the use of Asenapine (Merck-P06107)
    • Study Details: The purpose of the study is to evaluate the efficacy and safety of 3-week fixed-dose Asenapine treatment in pediatric acute manic or mixed episodes associated with Bipolar I Disorder.
    • End Date: 2013
  • Pediatric Bipolar Disorder and the use of Asenapine (Merck-P05898)
    • Study Details: The study is a 26-week open-label, flexible-dose trial of Asenapine extension treatment to Merk-P06107 study in pediatric acute manic or mixed episodes associated with Bipolar I Disorder.
    • End Date: 2013
  • Child and Adolescent Clinical Research Registry
    • Study Details: The purpose is to gather information and create a registry of information about children and adolescents who are being evaluated for various psychiatric disorders. It is anticipated that the collective information contained within this registry will be used to help physicians learn more about these problems in children and adolescents and help them to develop more effective treatments. The registry will be used to estimate the number of people who have certain diseases and how many new cases of the disease occur. It will provide estimates of the type and results of health care given and allow researchers to track changes in the care over time. It will also allow research to compare the type and results of health care given to different types of patients and to identify patients who may be eligible to participate in clinical research studies.
    • End Date: None
  • Youth Coping Project (YCP)
    • Study Details: The Youth Coping project follows adolescents (age 13-17) for 6 weeks after a psychiatric hospitalization to examine how adolescents use coping skills to prevent self-harm behaviors.
    • End Date: 03/31/2011
  • PEP Telemedicine
    • Study Details: This study involves adaptation and evaluation of the feasibility of Psychoeducational Psychotherapy (PEP) for children with mood disorders delivered by televideo.
    • End Date: 05/14/2011
  • Tissue and DNA Repository
    • Study Details: The purpose of the repository is to conduct a variety of genetic studies on psychiatric conditions. The type of tissue used will be either a sample of blood or a sample of saliva. Our research is focused on identifying genes relevant to a variety of psychiatric conditions including but not limited to: disruptive behavior and mood disorder, particularly attention-deficit/hyperactivity disorder (ADHD) and bipolar disorder.
    • End Date: None

Research Faculty and Staff

Last modified: Oct 29, 2018
ID=x1531